Navigation Links
DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
Date:1/25/2008

t external Biotech Advisory Panel) and uses its Bioethics Guiding Principles for all biotech projects. For more information, visit http://www.sustainability.dupont.com.

The World Economic Forum is an independent international organization committed to improving the state of the world by engaging leaders in partnerships to shape global, regional and industry agendas. Incorporated as a foundation in 1971, and based in Geneva, Switzerland, the World Economic Forum is impartial and not-for-profit; it is tied to no political, partisan or national interests. (http://www.weforum.org).

DuPont Science & Technology provides technologies and transformational options for new and existing businesses, building on a long, rich legacy of leading-edge science and innovation. DuPont's focus is on connecting its unique technology with keen market insight and foresight to deliver solutions that make peoples lives better, safer and healthier. In 2007, DuPont commercialized over 1,200 new products with strong representation from all five growth platforms. Products commercialized over the last five years accounted for 36 percent of DuPont's total revenue.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.


'/>"/>
SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
2. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
3. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
4. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
5. DuPont Named Among Top Biotechnology Employers by Science Magazine
6. DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration
7. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
8. DuPont Leaders Brief Investors on Agriculture Businesses
9. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
10. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
11. Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):First phase of pan-tropical forest mapping debuting at COP15 2First phase of pan-tropical forest mapping debuting at COP15 3Study reveals H1N1 unexpected weakness 2Nanomedicine: Ending 'hit and miss' design 2Nanomedicine: Ending 'hit and miss' design 3Celebrity Dancer Karina Smirnoff Speaks Out for the First Time on How ADHD Has Impacted Her Life 57322 1Celebrity Dancer Karina Smirnoff Speaks Out for the First Time on How ADHD Has Impacted Her Life 57322 2Celebrity Dancer Karina Smirnoff Speaks Out for the First Time on How ADHD Has Impacted Her Life 57322 3Celebrity Dancer Karina Smirnoff Speaks Out for the First Time on How ADHD Has Impacted Her Life 57322 4Celebrity Dancer Karina Smirnoff Speaks Out for the First Time on How ADHD Has Impacted Her Life 57322 5Celebrity Dancer Karina Smirnoff Speaks Out for the First Time on How ADHD Has Impacted Her Life 57322 6Celebrity Dancer Karina Smirnoff Speaks Out for the First Time on How ADHD Has Impacted Her Life 57322 7Rib X Pharmaceuticals Inc Appoints Tony Zook of MedImmune to Board of Directors 14085 1Rib X Pharmaceuticals Inc Appoints Tony Zook of MedImmune to Board of Directors 14085 2Rib X Pharmaceuticals Inc Appoints Tony Zook of MedImmune to Board of Directors 14085 3BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L Barker as Advisers 14082 1BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L Barker as Advisers 14082 2BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L Barker as Advisers 14082 3BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L Barker as Advisers 14082 4